Related Experiment Video
Updated: Apr 16, 2026

Tissue Engineering of the Intestine in a Murine Model
Published on: December 1, 2012
[Short bowel syndrome and failure intestinal features in our community]
Jose Carlos Salazar Quero1, Javier Blasco Alonso2, Aurora Pérez Parras3
1Unidad de Gastroenterología, Hepatología y Nutrición Pediátricas. HHUU Virgen del Rocío.. josesolrac@hotmail.com.
Insights
Early enteral nutrition and reduced lipids in parenteral nutrition improve outcomes for pediatric short bowel syndrome (SBS) and intestinal failure (IF). These interventions help prevent liver disease and promote enteral autonomy in affected children.
Area of Science:
- Pediatric Gastroenterology
- Surgical Gastroenterology
- Clinical Nutrition
Context:
- Intestinal failure (IF) and short bowel syndrome (SBS) are increasingly prevalent in pediatric populations, often resulting from extensive bowel resections.
- Management of IF/SBS requires specialized care to ensure adequate nutrition and prevent complications.
Purpose:
- To investigate the prevalence, etiology, and management of SBS and IF in Andalusia.
- To analyze factors influencing patient outcomes, including transplant rates and time to enteral autonomy.
- To identify differences in clinical management across participating centers.
Summary:
- A multicenter retrospective study analyzed 25 pediatric patients diagnosed with SBS or IF between 2008 and 2014.
- Key findings indicate that early enteral nutrition introduction favors parenteral nutrition (PN) suspension and reduces the risk of parenteral nutrition-associated liver disease (PNALD).
- Reduced lipid administration in PN, longer remnant intestinal length, and earlier enteral nutrition also correlate with better PNALD prevention.
Impact:
- Highlights the critical role of early enteral nutrition in achieving enteral autonomy and improving outcomes for pediatric patients with SBS/IF.
- Provides evidence supporting specific nutritional strategies, such as reduced lipid PN, to mitigate complications like PNALD.
- Informs clinical practice guidelines for managing pediatric intestinal failure and short bowel syndrome.
Introduction:
Intestinal failure is being an entity with higher prevalence in the pediatric age, especially due to bowel resections causing the appearance of a short bowel syndrome.
Objectives:
To determine the prevalence and etiology of cases of short bowel syndrome (SIC) and Intestinal Failure (FI) existing in Andalusia. Analyze factors involved in evolution, the number of transplant patients and to know the time required to achieve enteral autonomy, studying whether there are differences in management between different participants.
Methods:
Multicenter retrospective descriptive observational study in which are collected data of patients diagnosed with short bowel syndrome or intestinal failure in 6 hospitals in Andalusia in the period from 1 January 2008 to 31 January 2014.
Results:
25 patients. Average age at diagnosis 7.4 months. Average length of remnant intestine: 113.8 cm; 64% of patients with <75 cm length remaining intestine. We show that: the early introduction of enteral nutrition is a factor favoring the suspension of the NP (p = 0'033); and that the prevention of liver disease associated with parenteral nutrition (EHANP) is favored by: the use of fewer lipid Parenteral Nutrition (p = 0'008), a greater length of remaining intestine (p = 0'049 ), the early introduction of enteral nutrition (p = 0'009) and a lower gestational age (p = 0'006).
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

